News
This article is in the news archive. Glaxosmithkline teams up with Cambridge to deliver new medicinesGSK has signed its first agreement with the University of Cambridge, which will dedicate a team of academic experts in both neuroscience and metabolic disorders, to develop a novel centrally-acting agent with therapeutic potential for obesity and addictive disorders. For more information please click here. Posted on 30/07/2008 Further newsGo to the news index page. |